E-Vita Open Neo - Graft, vascular, synthetic

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Disponível em:

Cryolife Medical (Australia) Company Pty Ltd

Classe:

Class III

Fabricado por:

Jotec GmbH Lotzenacker 23, Hechingen, 72379 Germany

Área terapêutica:

35281 - Graft, vascular, synthetic

Indicações terapêuticas:

The E-vita OPEN NEO implant consists of a vascular graft part and a stent graft part. The vascular graft part of the E-vita OPEN NEO implant has circular crimps that provide the neces-sary form stability and allow to longitudinal stretching for adaption to the anatomy. At the vascular graft part, there is a perfusion branch which may be used for the extracorporeal perfusion during the intervention. E-vita OPEN NEO is intended for the surgical treatment of dissections or aneurysms in the aortic arch and the descending thoracic aorta with or without involvement of the ascending aorta.

Status de autorização:

A

Data de autorização:

2021-09-13